The London Melanonychia Assessment Tool for the identification of malignant lesions in patients presenting with melanonychia.

IF 1.8 4区 医学 Q3 DERMATOLOGY
Melanoma Research Pub Date : 2026-06-01 Epub Date: 2026-04-28 DOI:10.1097/CMR.0000000000001085
Zak Vinnicombe, Masha Singh, Joy Odili, Mark Soldin
{"title":"The London Melanonychia Assessment Tool for the identification of malignant lesions in patients presenting with melanonychia.","authors":"Zak Vinnicombe, Masha Singh, Joy Odili, Mark Soldin","doi":"10.1097/CMR.0000000000001085","DOIUrl":null,"url":null,"abstract":"<p><p>Longitudinal melanonychia is a pigmented band on the nail plate that may be caused by both benign or malignant changes. There is often concern that the pigment may indicate subungual melanoma or melanoma in-situ and the diagnosis can be challenging. Consequently, a scoring system that aids clinicians in identifying high-risk lesions will be beneficial. This was a retrospective, cohort analysis of patients undergoing nail unit biopsies, with clinical images available, at a tertiary skin cancer unit. Patient images were reviewed by skin cancer specialists, and a new scoring system was applied. Scoring characteristics were: nail dystrophy, more than 40% nail involvement, Hutchinson's sign, and asymmetry. The number of nails involved (i.e. single or multiple) and the change over time were also obtained from the clinical notes. Median scores for each patient were then calculated, and a receiver operating characteristic curve was utilized to identify the score with the highest sensitivity and specificity. Seven malignant and 33 benign lesions were included. Utilizing a score of greater than or equal to 4, the London Melanonychia Assessment Tool (LMAT) had a sensitivity of 86% and a specificity of 73%. There is increasing pressure on skin cancer units, with greater numbers of urgent referrals. Although other tools for the assessment of melanonychia have been published, the LMAT includes a wide variety of lesions, making it transferable to clinical practice. The LMAT may help clinicians in identifying lesions that are higher risk and therefore should undergo biopsy or closer monitoring.</p>","PeriodicalId":18550,"journal":{"name":"Melanoma Research","volume":" ","pages":"197-202"},"PeriodicalIF":1.8000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Melanoma Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/CMR.0000000000001085","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/28 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Longitudinal melanonychia is a pigmented band on the nail plate that may be caused by both benign or malignant changes. There is often concern that the pigment may indicate subungual melanoma or melanoma in-situ and the diagnosis can be challenging. Consequently, a scoring system that aids clinicians in identifying high-risk lesions will be beneficial. This was a retrospective, cohort analysis of patients undergoing nail unit biopsies, with clinical images available, at a tertiary skin cancer unit. Patient images were reviewed by skin cancer specialists, and a new scoring system was applied. Scoring characteristics were: nail dystrophy, more than 40% nail involvement, Hutchinson's sign, and asymmetry. The number of nails involved (i.e. single or multiple) and the change over time were also obtained from the clinical notes. Median scores for each patient were then calculated, and a receiver operating characteristic curve was utilized to identify the score with the highest sensitivity and specificity. Seven malignant and 33 benign lesions were included. Utilizing a score of greater than or equal to 4, the London Melanonychia Assessment Tool (LMAT) had a sensitivity of 86% and a specificity of 73%. There is increasing pressure on skin cancer units, with greater numbers of urgent referrals. Although other tools for the assessment of melanonychia have been published, the LMAT includes a wide variety of lesions, making it transferable to clinical practice. The LMAT may help clinicians in identifying lesions that are higher risk and therefore should undergo biopsy or closer monitoring.

伦敦黑色素瘤评估工具,以确定恶性病变的患者呈现黑色素瘤。
纵向黑甲是甲板上的色素带,可由良性或恶性变化引起。人们经常担心这种色素可能表明甲下黑色素瘤或原位黑色素瘤,诊断可能具有挑战性。因此,一个有助于临床医生识别高风险病变的评分系统将是有益的。这是一个回顾性的队列分析,患者接受指甲单位活检,有临床图像,在三级皮肤癌单位。皮肤癌专家对患者图像进行了审查,并应用了一种新的评分系统。评分特征包括:指甲营养不良、超过40%的指甲受累、哈钦森氏征和不对称。所涉及的指甲数量(即单个或多个)以及随时间的变化也从临床记录中获得。然后计算每位患者的中位评分,并利用受试者工作特征曲线确定灵敏度和特异性最高的评分。包括7个恶性病变和33个良性病变。伦敦黑色素瘤评估工具(LMAT)的评分大于等于4分,灵敏度为86%,特异性为73%。随着越来越多的紧急转诊,皮肤癌单位面临越来越大的压力。虽然已经发表了其他评估黑色素瘤的工具,但LMAT包括各种各样的病变,使其可转移到临床实践。LMAT可以帮助临床医生识别高风险病变,因此应该进行活检或更密切的监测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Melanoma Research
Melanoma Research 医学-皮肤病学
CiteScore
3.40
自引率
4.50%
发文量
139
审稿时长
6-12 weeks
期刊介绍: ​​​​​​Melanoma Research is a well established international forum for the dissemination of new findings relating to melanoma. The aim of the Journal is to promote the level of informational exchange between those engaged in the field. Melanoma Research aims to encourage an informed and balanced view of experimental and clinical research and extend and stimulate communication and exchange of knowledge between investigators with differing areas of expertise. This will foster the development of translational research. The reporting of new clinical results and the effect and toxicity of new therapeutic agents and immunotherapy will be given emphasis by rapid publication of Short Communications. ​Thus, Melanoma Research seeks to present a coherent and up-to-date account of all aspects of investigations pertinent to melanoma. Consequently the scope of the Journal is broad, embracing the entire range of studies from fundamental and applied research in such subject areas as genetics, molecular biology, biochemistry, cell biology, photobiology, pathology, immunology, and advances in clinical oncology influencing the prevention, diagnosis and treatment of melanoma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书